Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zilis is a private U.S.-based health and wellness company founded in 2015 that markets hemp-derived cannabinoid products, dietary supplements, skincare products, and pet wellness products through a direct selling model. The company emphasizes its proprietary UltraCell delivery technology, which it says improves bioavailability of certain liquid wellness formulations, and it also markets Precision Spectrum cannabinoid formulations. Zilis appears focused on commercialized consumer wellness products rather than prescription drug development, and its website explicitly states that its products are not intended to diagnose, treat, cure, or prevent disease. The company operates across the United States, Latin America, and Europe and is led by CEO and owner Angie Thompson.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zilis.